https://www.yiliao.com/index.php?action=history&feed=atom&title=%E5%88%86%E5%AD%90%E5%A4%8D%E5%8F%91
分子复发 - 版本历史
2026-04-19T08:06:09Z
本wiki的该页面的版本历史
MediaWiki 1.35.1
https://www.yiliao.com/index.php?title=%E5%88%86%E5%AD%90%E5%A4%8D%E5%8F%91&diff=316130&oldid=prev
2026年1月29日 (四) 00:15 77921020
2026-01-29T00:15:48Z
<p></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="zh-Hans-CN">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">2026年1月29日 (四) 00:15的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l60" >第60行：</td>
<td colspan="2" class="diff-lineno">第60行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <br>残留的肿瘤细胞在微环境中通过免疫逃逸逐渐增殖。当肿瘤负荷超过分子检测技术的检测下限（LOD，如 0.01% VAF）时，血液中即可测得 ctDNA，即为<strong>分子复发</strong>。</li></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <br>残留的肿瘤细胞在微环境中通过免疫逃逸逐渐增殖。当肿瘤负荷超过分子检测技术的检测下限（LOD，如 0.01% VAF）时，血液中即可测得 ctDNA，即为<strong>分子复发</strong>。</li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <li style="margin-bottom: 12px;"><strong>临床显现 (Clinical Manifestation)：</strong> </div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <li style="margin-bottom: 12px;"><strong>临床显现 (Clinical Manifestation)：</strong> </div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> <br>若不进行干预，肿瘤细胞继续指数级增长，最终形成肉眼可见的肿块（直径 > <del class="diffchange diffchange-inline">1cm），此时才被 </del>CT/MRI 发现，即为<strong>临床复发</strong>。</li></div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> <br>若不进行干预，肿瘤细胞继续指数级增长，最终形成肉眼可见的肿块（直径 > <ins class="diffchange diffchange-inline">1cm，细胞数 > 10<sup>9</sup>），此时才被 </ins>CT/MRI 发现，即为<strong>临床复发</strong>。</li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </ul></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </ul></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l74" >第74行：</td>
<td colspan="2" class="diff-lineno">第74行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <tr></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <tr></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">肿瘤负荷</td></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">肿瘤负荷</td></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> <td style="padding: 10px; border: 1px solid #cbd5e1;">微量 (<del class="diffchange diffchange-inline">$</del>10<del class="diffchange diffchange-inline">^</del>6 - 10<del class="diffchange diffchange-inline">^</del>9<del class="diffchange diffchange-inline">$ </del>细胞)</td></div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> <td style="padding: 10px; border: 1px solid #cbd5e1;">微量 (10<ins class="diffchange diffchange-inline"><sup></ins>6<ins class="diffchange diffchange-inline"></sup> </ins>- 10<ins class="diffchange diffchange-inline"><sup></ins>9<ins class="diffchange diffchange-inline"></sup> </ins>细胞)</td></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> <td style="padding: 10px; border: 1px solid #cbd5e1;">宏量 (> <del class="diffchange diffchange-inline">$10^</del>9<del class="diffchange diffchange-inline">$ </del>细胞, <del class="diffchange diffchange-inline">></del>1g)</td></div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> <td style="padding: 10px; border: 1px solid #cbd5e1;">宏量 (<ins class="diffchange diffchange-inline">&gt; 10<sup</ins>>9<ins class="diffchange diffchange-inline"></sup> </ins>细胞, <ins class="diffchange diffchange-inline">&gt;</ins>1g)</td></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </tr></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </tr></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <tr></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> <tr></div></td></tr>
</table>
77921020
https://www.yiliao.com/index.php?title=%E5%88%86%E5%AD%90%E5%A4%8D%E5%8F%91&diff=316129&oldid=prev
77921020：建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面
2026-01-29T00:12:27Z
<p>建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面</p>
<p><b>新页面</b></p><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"><br />
<br />
<div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;"><br />
<p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"><br />
<strong>分子复发</strong>（Molecular Recurrence），又称生化复发或亚临床复发，是指在恶性肿瘤患者经过治疗达到临床完全缓解（CR）后，通过高灵敏度的生物技术（如 NGS、ddPCR）在血液或其他体液中再次检测到特异性的肿瘤标志物（如 <strong>ctDNA</strong>、融合基因 mRNA、异常蛋白），但此时影像学（CT/MRI）尚未发现可见病灶，且患者无临床症状的状态。分子复发通常比临床复发提前 3-9 个月，是<strong>微小残留病灶 (MRD)</strong> 由阴转阳的直接体现，为“抢先治疗”提供了关键的时间窗口。<br />
</p><br />
</div><br />
<br />
<div class="medical-infobox mw-collapsible mw-collapsed" style="width: 100%; max-width: 320px; margin: 0 auto 35px auto; border: 1.2px solid #bae6fd; border-radius: 12px; background-color: #ffffff; box-shadow: 0 8px 20px rgba(0,0,0,0.05); overflow: hidden;"><br />
<br />
<div style="padding: 15px; color: #1e40af; background: linear-gradient(135deg, #e0f2fe 0%, #bae6fd 100%); text-align: center; cursor: pointer;"><br />
<div style="font-size: 1.2em; font-weight: bold; letter-spacing: 1.2px;">分子复发</div><br />
<div style="font-size: 0.7em; opacity: 0.85; margin-top: 4px; white-space: nowrap;">Molecular / Biochemical Recurrence (点击展开)</div><br />
</div><br />
<br />
<div class="mw-collapsible-content"><br />
<div style="padding: 25px; text-align: center; background-color: #f8fafc;"><br />
<br />
<div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">时间轴：分子复发早于影像学</div><br />
</div><br />
<br />
<table style="width: 100%; border-spacing: 0; border-collapse: collapse; font-size: 0.85em;"><br />
<tr><br />
<th colspan="2" style="padding: 8px 12px; background-color: #e0f2fe; color: #1e40af; text-align: left; font-size: 0.9em; border-top: 1px solid #bae6fd;">临床特征</th><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0; width: 40%;">核心指标</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">MRD 阳性 (Re-emergence)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">检测靶标</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #1e40af;">ctDNA, CTC, 融合基因</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">提前量 (Lead Time)</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #16a34a;">平均 3-9 个月</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">影像学表现</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #b91c1c;"><strong>阴性</strong> (无可见病灶)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569;">技术门槛</th><br />
<td style="padding: 6px 12px; color: #0f172a;">LOD &lt; 0.01%</td><br />
</tr><br />
</table><br />
</div><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">发生机制：冰山下的暗流</h2><br />
<br />
<p style="margin: 15px 0; text-align: justify;"><br />
分子复发是肿瘤克隆演化和耐药克隆扩增的早期表现，其生物学过程可以形象地用“冰山理论”解释：<br />
</p><br />
<br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>隐匿残留 (Occult Residual)：</strong> <br />
<br>手术或化疗后，绝大部分肿瘤细胞被清除，影像学显示“无病状态”。但体内仍残留极少量耐药克隆（低于常规检测下限）。</li><br />
<li style="margin-bottom: 12px;"><strong>克隆扩增 (Clonal Expansion)：</strong> <br />
<br>残留的肿瘤细胞在微环境中通过免疫逃逸逐渐增殖。当肿瘤负荷超过分子检测技术的检测下限（LOD，如 0.01% VAF）时，血液中即可测得 ctDNA，即为<strong>分子复发</strong>。</li><br />
<li style="margin-bottom: 12px;"><strong>临床显现 (Clinical Manifestation)：</strong> <br />
<br>若不进行干预，肿瘤细胞继续指数级增长，最终形成肉眼可见的肿块（直径 > 1cm），此时才被 CT/MRI 发现，即为<strong>临床复发</strong>。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">复发阶段对比：分子 vs 影像</h2><br />
<br />
<div style="overflow-x: auto; margin: 20px auto;"><br />
<table style="width: 100%; border-collapse: collapse; border: 1.2px solid #cbd5e1; font-size: 0.9em; text-align: left;"><br />
<tr style="background-color: #f1f5f9; border-bottom: 2px solid #0f172a;"><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #0f172a; width: 20%;">维度</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #475569; width: 35%;">分子复发 (Molecular)</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #1e40af;">临床复发 (Clinical)</th><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">肿瘤负荷</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">微量 ($10^6 - 10^9$ 细胞)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">宏量 (> $10^9$ 细胞, >1g)</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">检测手段</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">液体活检 (ctDNA), BCR-ABL (qPCR)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">CT, MRI, PET-CT</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">患者状态</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">无症状</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">可能伴有疼痛、消瘦等</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">治疗目标</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;"><strong>治愈 / 逆转</strong> (Curative)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">控制 / 姑息 (Palliative)</td><br />
</tr><br />
</table><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">干预策略：抢先治疗 (Pre-emptive Therapy)</h2><br />
<br />
<div style="background-color: #f0f9ff; border-left: 5px solid #1e40af; padding: 15px 20px; margin: 20px 0; border-radius: 4px;"><br />
<h3 style="margin-top: 0; color: #1e40af; font-size: 1.1em;">实体瘤中的应用</h3><br />
<p style="margin-bottom: 0; text-align: justify; font-size: 0.95em; color: #334155;"><br />
在结直肠癌和肺癌中，一旦确认为分子复发（如连续两次 ctDNA 阳性且丰度上升），临床试验正探索提前启动治疗：<br />
<br>1. <strong>靶向药物重挑战：</strong> 对于 EGFR 突变肺癌，ctDNA 转阳可能提示耐药克隆复苏，可提前使用 TKI。<br />
<br>2. <strong>辅助化疗加强：</strong> 术后 MRD 阳性患者，接受辅助化疗获益显著；而持续阴性者可能豁免化疗（降阶梯治疗）。<br />
</p><br />
</div><br />
<br />
<div style="background-color: #fff7ed; border-left: 5px solid #ea580c; padding: 15px 20px; margin: 20px 0; border-radius: 4px;"><br />
<h3 style="margin-top: 0; color: #ea580c; font-size: 1.1em;">血液肿瘤的标准实践</h3><br />
<p style="margin-bottom: 0; text-align: justify; font-size: 0.95em; color: #334155;"><br />
在慢性髓系白血病 (CML) 中，<i>BCR-ABL</i> 融合基因水平升高（主要分子学反应丧失）是标准的分子复发，需立即更换 TKI 药物或通过异基因造血干细胞移植进行干预。<br />
</p><br />
</div><br />
<br />
<div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;"><br />
<span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献 [Academic Review]</span><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[1] <strong>Pantel K, Alix-Panabières C. (2019).</strong> <em>Liquid biopsy and minimal residual disease — latest advances and implications for cure.</em> <strong>[[Nature Reviews Clinical Oncology]]</strong>. <br><br />
<span style="color: #475569;">[点评]：权威综述，详细阐述了通过液体活检监测 MRD 及分子复发在实现癌症治愈中的核心作用。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[2] <strong>Chaudhuri AA, et al. (2017).</strong> <em>Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling.</em> <strong>[[Cancer Discovery]]</strong>. <br><br />
<span style="color: #475569;">[点评]：证明了 ctDNA 可比影像学平均提前 5.2 个月发现肺癌复发，奠定了分子复发的临床价值。</span><br />
</p><br />
<br />
<p style="margin: 12px 0;"><br />
[3] <strong>Tie J, et al. (2016).</strong> <em>Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.</em> <strong>[[Science Translational Medicine]]</strong>. <br><br />
<span style="color: #475569;">[点评]：结直肠癌领域的经典研究，确立了 ctDNA 作为复发高危预测因子的地位。</span><br />
</p><br />
</div><br />
<br />
<div style="margin: 40px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; font-family: 'Helvetica Neue', Arial, sans-serif; font-size: 0.9em;"><br />
<div style="background-color: #eff6ff; color: #1e40af; padding: 8px 15px; font-weight: bold; text-align: center; border-bottom: 1px solid #dbeafe;"><br />
肿瘤监测 · 知识图谱<br />
</div><br />
<table style="width: 100%; border-collapse: collapse; background-color: #ffffff;"><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">核心概念</td><br />
<td style="padding: 10px 15px; color: #334155;">[[微小残留病]] (MRD) • [[液体活检]] • [[提前量]] (Lead Time)</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">检测技术</td><br />
<td style="padding: 10px 15px; color: #334155;">[[ctDNA]] (循环肿瘤DNA) • [[NGS]] • [[PSA]] (生化复发特例)</td><br />
</tr><br />
<tr><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">临床决策</td><br />
<td style="padding: 10px 15px; color: #334155;">[[抢先治疗]] • [[动态监测]] • [[降阶梯治疗]]</td><br />
</tr><br />
</table><br />
</div><br />
<br />
</div></div>
77921020